Revascularisation Drivers

Cross-source consensus on Revascularisation Drivers from 1 sources and 5 claims.

1 sources · 5 claims

How it works

Optimal medical therapy and prevention policy are recognised contributors to AMI mortality decline. — Percutaneous coronary intervention, coronary artery bypass grafting and mortality from acute myocardial infarction in EU15+ countries, 2006–2020: a secondary analysis of the OECD database
Countries with more catheterisation laboratories per million people tended to have higher PCI rates. — Percutaneous coronary intervention, coronary artery bypass grafting and mortality from acute myocardial infarction in EU15+ countries, 2006–2020: a secondary analysis of the OECD database
Surgeon perception of high patient risk is cited as a common reason for fewer CABG procedures. — Percutaneous coronary intervention, coronary artery bypass grafting and mortality from acute myocardial infarction in EU15+ countries, 2006–2020: a secondary analysis of the OECD database
Public reporting of surgical outcomes may discourage operations on higher-risk or disadvantaged patients. — Percutaneous coronary intervention, coronary artery bypass grafting and mortality from acute myocardial infarction in EU15+ countries, 2006–2020: a secondary analysis of the OECD database
Low guideline adherence for optimal medical therapy may affect PCI utilisation patterns. — Percutaneous coronary intervention, coronary artery bypass grafting and mortality from acute myocardial infarction in EU15+ countries, 2006–2020: a secondary analysis of the OECD database